Why These 2 Medical Experts Want a New Stroke Treatment
Source: Streetwise Reports��(2/14/22)
In the Feb. 10 episode of Streetwise Live!, Host Cyndi Edwards interviews two medical experts who discuss the need for a new stroke treatment, explain why today's stroke treatments are so limited and express their excitement around what Algernon Pharmaceuticals is testing with DMT.

More >

Mental Health Co. Brings Psychedelics to the World
Source: Streetwise Reports��(2/9/22)
In Citi's Jan. 25, 2022 Psychedelic Call Series broadcast, Novamind CEO Yaron Conforti and Chief Medical Officer Dr. Reid Robison discussed how the company is increasing people's access to psychedelic therapies for mental health disorders. More >

Co. Looks to New Structures of Psychedelic Drug for Strokes
Source: Streetwise Reports��(1/25/22)
Algernon Pharmaceuticals Inc. has included novel salt forms of a psychedelic drug being investigated to combat strokes in its intellectual property applications. More >

GNC to Distribute Products for CBD Co.
��(1/22/22)
The agreement with GNC is a step toward Charlotte's Web Holdings' goals of expanding consumer access to its products and becoming cash flow positive this year, noted a ROTH Capital Partners report. More >

US Cannabis Firm in 'State of Flux'
��(1/19/22)
With several market factors working against Stem Holdings, its future is uncertain, noted a Noble Capital Markets report. More >

Trial of Psilocybin Therapeutic in Treatment Resistant Depression Yields Positive Topline Results
Source: Streetwise Reports��(11/14/21)
"We believe this data begins to form the basis of an approvable program for Compass Pathways' COMP360" in this indication, noted a BTIG report. More >

US DEA OKs Use of Psychedelics by This Mental Health Network
Source: Streetwise Reports��(11/9/21)
Clinics that deliver novel psychiatric treatment and host clinical trials of psychedelic medicine have positioned Novamind for breakthroughs in mental health treatment. More >

Psychedelic Drug Trials Accelerate as Decriminalization Spreads, Investment Expands
Source: McAlinden Research for Streetwise Reports��(11/3/21)
McAlinden Research Partners estimates it may be only a matter of time before psychedelics become part of a biotech boom. More >

Cannabis Firm to Enter Colorado Market Via Acquisition
Source: Streetwise Reports��(10/27/21)
The target company "brings numerous positives to Stem Holdings dba Driven By Stem," noted a Noble Capital markets report. More >

Company Releases iOS-Based App for Cannabis Purchase and Delivery
Source: Streetwise Reports��(10/14/21)
The potential is "enormous" for Stem Holdings Inc. dba Driven By Stem's new app, Budee Cannabis Delivery, given it is available in the Apple App Store, a Noble Capital Markets report noted. More >

Cannabis Firm Expands Footprint in Central California With New Distribution Center
Source: Streetwise Reports��(9/28/21)
"The expansion is expected to drive topline sales with greater efficiency," noted a Noble Capital Markets report. More >

Flora Shares Sprout Higher on H1 Financial Results and Positive FY Sales Outlook
Source: Streetwise Reports��(8/20/21)
Shares of natural cannabis firm Flora Growth Corp. rose 43% after the company reported H1/21 financial results and indicated it expects H2/21 revenues will be in the range of US$9-11 million. More >

Cannabis Products Retailer Achieves Record Sales in Q3 FY21
Source: Streetwise Reports��(8/17/21)
Gross sales of Stem Holdings dba Driven by Stem during the quarter were 104% higher than they were a year ago. More >

U.S. Cannabis Sector to Show 'Secular Growth With Margin Improvements,' Analyst Says
Source: Streetwise Reports��(8/11/21)
Behind that forecast, in part, are positive cannabis legislative developments and increasing consumer cannabis use, which are covered in a ROTH Capital Partners report. More >

Tilray Shares Fly High on Strong Q4 and FY Revenue Growth
Source: Streetwise Reports��(7/28/21)
Shares of Tilray Inc. traded 25% higher after the company reported FY/21 financial results that included a 27% YoY increase in net revenues to $513.1 million driven by a 55% growth in cannabis revenue following its Aphria acquisition. More >

Cannabis Market Delivering for Consumers and Investors
Source: Streetwise Reports��(7/21/21)
As legalization takes hold across the U.S., opportunities for the next generation of cannabis companies expand. Adrian Morante of K2 & Associates finds “trustworthy, capable and reputable” companies with value. More >

US Cannabis Sales Hold Strong as Industry Lays Out New Lobbying Efforts to Expedite Federal Reform
Source: McAlinden Research for Streetwise Reports��(7/14/21)
McAlinden Research Partners expects activity and revenues in the cannabis space to continue ramping up as the US crosses the point at which legalization is not a question of "if" but "when." More >

Pharma Company Working to Unlock Psychedelic Drug's Potential for Stroke Recovery
Source: Streetwise Reports��(7/9/21)
Algernon Pharmaceuticals CEO Christopher J. Moreau and Dr. David Nutt, the company's research stroke consultant, discuss Algernon's upcoming Phase 1 study of DMT for stroke. More >

Tilray Shares Climb Higher on Roll Out of New Medical Cannabis Brand Symbios
Source: Streetwise Reports��(6/9/21)
Tilray Inc. shares traded 11% higher after the company reported the launch of a new medical cannabis brand, Symbios, designed to provide medicinal users with a broader spectrum of formats and cannabinoid potencies at improved price points. More >

Promising Psychedelic Drug Trials Show Potential for a New Biotech Boom
Source: McAlinden Research for Streetwise Reports��(6/4/21)
McAlinden Research Partners notes that continued advances in psychedelic therapies show potential to drive an investment boom that could reshape the future of medicine and mental health therapies. More >

Firm Doubles in Size by Adding Four New Psychedelic Mental Health Clinics
Source: Streetwise Reports��(5/5/21)
Novamind Inc. is opening four new psychedelic mental health clinics as part of the company's national expansion strategy, giving it the capability to conduct 65,000 client visits in 2021. More >

Merck Selects Rapidly Growing Psychedelic Medicine Company as Key Research Site
Source: Streetwise Reports��(4/16/21)
Novamind runs clinics, research sites and therapeutic retreats and is positioning itself for expansion. More >

Investor Campbell Becher's Three Core Assets
Source: Streetwise Reports��(3/22/21)
The former Bay Street investment banker is finding himself going narrower and deeper. More >

U.S. Cannabis Company 'Cashed Up with Catalysts Materializing'
Source: Streetwise Reports��(2/24/21)
The many reasons why Columbia Care is 'due for a catch-up trade' are discussed in an Echelon Capital Markets report. More >

As Psychedelics Move Mainstream, Small Cap Positions Itself at the Center of the Industry
Source: Streetwise Reports��(1/13/21)
Two year old DELIC Corp. has gotten in on the ground floor of the nascent psychedelic sector. More >